Hanselman Andrew E, Powell Brian D, Santrock Robert D
Orthopedics. 2015 Apr;38(4):e343-6. doi: 10.3928/01477447-20150402-91.
Advancements in total ankle arthroplasty (TAA) over the past several decades have led to improved patient outcomes and implant survivorship. Despite these innovations, many implant manufacturers still consider a preoperative coronal plane deformity greater than 10° a relative contraindication to TAA. Without proper intraoperative alignment, these implants may experience abnormal wear and hardware failure. Correcting these deformities, often through the use of soft tissue procedures and/or osteotomies, not only increases the difficulty of a case, but also the intraoperative time and radiation exposure. The authors report a case in which a 54-year-old man with a severe right ankle varus deformity of 29° underwent successful TAA using the INBONE II Prophecy total ankle system (Wright Medical Technology, Inc, Memphis, Tennessee) and additional soft tissue reconstruction. Intraoperatively, the patient's coronal deformity was corrected to 1.8°. At 8 months postoperatively, the patient ambulated without restriction and had substantial improvement in validated patient outcome scores, specifically the Academy of Orthopaedic Surgeons Foot and Ankle Module and the Short Form Health Survey-12 This unique report documents the first time that this particular implant, with an exclusive preoperative computed tomography-derived patient-specific guide, has been used effectively for a severe preoperative varus deformity greater than 20° without the need for an osteotomy. Future studies should be directed toward the prospective evaluation of different total ankle implant systems and their outcomes with severe coronal plane deformity, specifically computed tomography-derived patient-specific guided implants.
在过去几十年中,全踝关节置换术(TAA)取得了进展,使患者预后和植入物存活率得到改善。尽管有这些创新,但许多植入物制造商仍将术前冠状面畸形大于10°视为TAA的相对禁忌证。如果术中没有正确对齐,这些植入物可能会出现异常磨损和硬件故障。通常通过使用软组织手术和/或截骨术来纠正这些畸形,这不仅增加了手术难度,还延长了术中时间并增加了辐射暴露。作者报告了一例病例,一名54岁男性,右踝关节严重内翻畸形达29°,使用INBONE II Prophecy全踝关节系统(Wright Medical Technology, Inc, 田纳西州孟菲斯)并进行了额外的软组织重建,成功接受了TAA。术中,患者的冠状面畸形被纠正至1.8°。术后8个月,患者可自由行走,经过验证的患者预后评分有显著改善,特别是美国骨科医师学会足踝模块评分和简短健康调查问卷-12评分。这份独特的报告首次记录了这种特殊的植入物,凭借其术前计算机断层扫描衍生的患者特异性导板,在无需截骨术的情况下有效用于大于20°的严重术前内翻畸形。未来的研究应针对不同全踝关节植入系统及其在严重冠状面畸形情况下的预后进行前瞻性评估,特别是计算机断层扫描衍生的患者特异性导板植入物。